Literature DB >> 17641416

Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas.

Marta Alonso Guervós1, César Alvarez Marcos, Mario Hermsen, Andrés Sampedro Nuño, Carlos Suárez, José Luis Llorente.   

Abstract

BACKGROUND: Lymph node metastasis is the mayor cause of mortality in patients with head and neck squamous cell carcinomas (45%). The genetic changes underlying metastasis are still largely unknown and genetic markers to predict lymph node positivity still need to be found. The aim of this study was to search such markers by using Multiplex Ligation-dependent Probe Amplification (MLPA), a semi-quantitative PCR technique to detect gene copy number alterations.
METHODS: Thirty-seven genes were analysed by MLPA in 34 larynx and 22 pharynx carcinomas.
RESULTS: Losses of CDKN2A (9p21) and MLH1 (3p22) and gains of CCND1, EMS1 (both at 11q13), RECQL4 and PTP4A3 (both at 8q24) were the most frequent aberrations in both larynx and pharynx carcinomas. Amplifications were detected at EMS1, CCND1 and ERBB2 (17q21). A correlation between loss of N33 (8p22) and poor survival was found (p=0.02). Gain of EMS1 had the same relation with survival but not significant (p=0.08). Lymph node positive tumors presented a specific pattern of genetic alterations, with losses of N33, STK11 (19p13) and TP53 (17p13), the latter especially in larynx tumors.
CONCLUSION: We propose that these 3 genes might play a role in the development of metastasis in larynx and pharynx squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641416      PMCID: PMC4618212          DOI: 10.1155/2007/635962

Source DB:  PubMed          Journal:  Cell Oncol        ISSN: 1570-5870            Impact factor:   6.730


  13 in total

1.  LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma.

Authors:  Wenjin Liu; Kimberly B Monahan; Adam D Pfefferle; Takeshi Shimamura; Jessica Sorrentino; Keefe T Chan; David W Roadcap; David W Ollila; Nancy E Thomas; Diego H Castrillon; C Ryan Miller; Charles M Perou; Kwok-Kin Wong; James E Bear; Norman E Sharpless
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

2.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

Review 3.  TUSC3: functional duality of a cancer gene.

Authors:  Kateřina Vašíčková; Peter Horak; Petr Vaňhara
Journal:  Cell Mol Life Sci       Date:  2017-09-19       Impact factor: 9.261

4.  Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer.

Authors:  Uta Duppel; Matthias Woenckhaus; Christian Schulz; Johannes Merk; Wolfgang Dietmaier
Journal:  Oncol Lett       Date:  2016-08-01       Impact factor: 2.967

Review 5.  ErbB receptors in the biology and pathology of the aerodigestive tract.

Authors:  Sarah Morgan; Jennifer R Grandis
Journal:  Exp Cell Res       Date:  2008-08-23       Impact factor: 3.905

6.  Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.

Authors:  Jian Huang; Da-Li Zheng; Feng-Song Qin; Na Cheng; Hui Chen; Bing-Bing Wan; Yu-Ping Wang; Hua-Sheng Xiao; Ze-Guang Han
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

7.  The influence of the CHIEF pathway on colorectal cancer-specific mortality.

Authors:  Martha L Slattery; Abbie Lundgreen
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.

Authors:  Xinshuang Yu; Jiandong Zhang; Hua Zhong; Fengjun Liu; Ning Liang; Yao Wang; Xiangjiao Meng; Juan Du
Journal:  Int J Med Sci       Date:  2016-11-25       Impact factor: 3.738

Review 9.  TUSC3: a novel tumour suppressor gene and its functional implications.

Authors:  Xinshuang Yu; Chunjuan Zhai; Yujun Fan; Jiandong Zhang; Ning Liang; Fengjun Liu; Lili Cao; Jia Wang; Juan Du
Journal:  J Cell Mol Med       Date:  2017-03-08       Impact factor: 5.310

10.  SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.

Authors:  Kuancan Liu; Fuan Xie; Anding Gao; Rui Zhang; Long Zhang; Zhangwu Xiao; Qiong Hu; Weifeng Huang; Qiaojia Huang; Baoshun Lin; Jian Zhu; Haikun Wang; Jianwen Que; Xiaopeng Lan
Journal:  Mol Cancer       Date:  2017-03-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.